<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>Computational Drug Discovery Portfolio</title>
  <style>
    body {
      margin: 0;
      font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
      background: linear-gradient(135deg, #0b0c2a, #1f003b);
      color: #f0f0f0;
      scroll-behavior: smooth;
      position: relative;
      overflow-x: hidden;
      background-image: url('img12.png');
      background-size: cover;
      background-position: center;
      background-attachment: fixed;
    }
    body::before, body::after {
      content: "";
      position: absolute;
      width: 200px;
      height: 200px;
      background: radial-gradient(circle, #bb86fc55, transparent);
      z-index: 0;
      animation: float 8s ease-in-out infinite;
    }
    body::before {
      top: 10%;
      left: 5%;
    }
    body::after {
      bottom: 10%;
      right: 5%;
    }
    @keyframes float {
      0%, 100% { transform: translateY(0); }
      50% { transform: translateY(-20px); }
    }
    header {
      padding: 60px 30px;
      text-align: center;
      position: relative;
      z-index: 1;
    }
    header h1 {
      font-size: 3em;
      margin-bottom: 10px;
    }
    header p {
      font-size: 1.2em;
      max-width: 800px;
      margin: auto;
    }
    nav {
      display: flex;
      justify-content: center;
      background-color: rgba(26, 26, 26, 0.85);
      backdrop-filter: blur(10px);
      padding: 10px;
      position: sticky;
      top: 0;
      z-index: 1000;
    }
    nav a {
      color: #f0f0f0;
      margin: 0 20px;
      text-decoration: none;
      font-weight: bold;
      padding: 8px 12px;
      border-radius: 8px;
      transition: all 0.3s ease;
      position: relative;
    }
    nav a::after {
      content: '';
      position: absolute;
      bottom: -2px;
      left: 50%;
      width: 0;
      height: 2px;
      background-color: #bb86fc;
      transition: width 0.3s ease, left 0.3s ease;
    }
    nav a:hover::after {
      width: 100%;
      left: 0;
    }
    nav a:hover {
      background: radial-gradient(circle at top left, #bb86fc44, #2c003d33);
      color: #ffffff;
      box-shadow: 0 0 10px #bb86fc, 0 0 20px #bb86fc66;
    }
    section {
      padding: 60px 30px;
      background: linear-gradient(145deg, #1a1a2e, #2f0a3c);
      box-shadow: inset 0 0 30px rgba(187, 134, 252, 0.2);
      text-align: center;
    }
    section h2 {
      margin-bottom: 20px;
    }
    section img {
      width: 100%;
      max-width: 500px;
      border-radius: 12px;
      box-shadow: 0 0 20px rgba(255, 255, 255, 0.1);
      margin-bottom: 10px;
    }
    .caption {
      font-size: 0.95em;
      color: #ccc;
      margin-bottom: 40px;
    }
    p {
      line-height: 1.6;
      font-size: 1.05em;
      max-width: 800px;
      margin: 0 auto 30px auto;
    }
    footer {
      text-align: center;
      padding: 30px 20px;
      background: linear-gradient(to right, #1f003b, #0b0c2a);
      color: #ccc;
      font-size: 0.9em;
    }
  </style>
</head>
<body>
  <header>
    <h1>Computational Drug Discovery Portfolio</h1>
    <h3>by Maneesh Kumar Paradarami</h3>
    <p>An end-to-end data science project exploring bioactivity prediction and cheminformatics-based drug discovery using ChEMBL data.</p>
  </header>
  <nav>
    <a href="#part1">Bioactivity Data Extraction</a>
    <a href="#part2">Descriptor Calculation & EDA</a>
    <a href="#part3"> Data Preparation</a>
    <a href="#part4">Regression Modeling</a>
    <a href="#part5">Model Comparisn</a>
  </nav>

  <section id="part1">
    <h2>Part 1: Bioactivity Data Extraction</h2>
    <p>We start by retrieving relevant data from ChEMBL focused on acetylcholinesterase inhibitors. Ensuring the dataset is balanced, we distinguish active and inactive compounds.</p>
    <p>This plot provides an overview of the frequency distribution of active vs inactive compounds across our dataset.</p>
    <img src="img1.png" alt="Bar chart of activity" />
    <div class="caption">Image 1: Frequency of Active vs Inactive compounds in ChEMBL data.</div>
  </section>

  <section id="part2">
    <h2>Part 2: Descriptor Calculation & EDA</h2>

    <p>We examine how lipophilicity (logP) varies across activity groups using statistical tests.</p>
    <img src="img2.png" alt="LogP vs Mann-Whitney test" />
    <div class="caption">Image 2: Mann-Whitney U test of logP between active/inactive compounds.</div>

    <p>This boxplot shows how pIC50 values differ across compound classes.</p>
    <img src="img3.png" alt="pIC50 value boxplot" />
    <div class="caption">Image 3: Distribution of pIC50 values for actives vs inactives.</div>

    <p>Molecular weight is another key feature in drug-likeness. Here we visualize its correlation with bioactivity.</p>
    <img src="img4.png" alt="MW boxplot" />
    <div class="caption">Image 4: Molecular weight vs bioactivity class.</div>

    <p>We analyze combined effects of logP and MW on compound classification.</p>
    <img src="img5.png" alt="LogP vs MW boxplot" />
    <div class="caption">Image 5: Joint boxplot of logP and MW across activity labels.</div>

    <p>Hydrogen bond donors can influence compound permeability. This boxplot shows the trends.</p>
    <img src="img6.png" alt="H-donors vs activity" />
    <div class="caption">Image 6: Number of H-donors vs bioactivity class.</div>

    <p>This scatter plot shows the continuous relationship between logP and MW.</p>
    <img src="img7.png" alt="Scatter plot logP vs MW" />
    <div class="caption">Image 7: Scatter plot of logP vs Molecular Weight.</div>
  </section>

  <section id="part3">
    <h2>Part 3: Data Preparation</h2>
    <p>To prepare the data for modeling, we normalize numerical features, clean missing values, and engineer new ones. This creates a stable foundation for training ML models by minimizing biases introduced by outliers and unscaled variables.</p>
  </section>

  <section id="part4">
    <h2>Part 4: Regression Modeling</h2>

    <p>The Random Forest regression model is trained to predict pIC50 based on computed molecular descriptors. Below is the regression line showing predicted vs actual values.</p>
    <img src="img8.png" alt="Regression performance plot" />
    <div class="caption">Image 8: Predicted vs Experimental pIC50 with regression line.</div>
  </section>

  <section id="part5">
    <h2>Part 5: Model Comparison</h2>

    <p>We evaluate multiple regression algorithms to determine the most effective model. Here we observe how different models perform across metrics like RMSE and R^2.</p>
    <img src="img9.png" alt="Model performance bar chart" />
    <div class="caption">Image 9: Comparison of multiple regression models.</div>

    <p>This chart compares predicted values across models, showing relative consistency and outliers.</p>
    <img src="img10.png" alt="Model prediction comparison" />
    <div class="caption">Image 10: Predicted pIC50 across different models.</div>

    <p>Lastly, we examine variance and robustness of each model’s performance across the test set.</p>
    <img src="img11.png" alt="Extended model comparison" />
    <div class="caption">Image 11: Extended performance metrics for ensemble and baseline models.</div>
  </section>

  <footer>
    <p>2025 Maneesh Kumar Paradarami | Built with HTML, CSS, and ❤️ for drug discovery.</p>
  </footer>
</body>
</html>
